Intra-amniotic infection during pregnancy increases the risk of obstetric complications and problems in the fetus and newborn, being commonly associated with premature delivery and adverse neonatal sequelae. The objective of this project is to evaluate the performance of a non-invasive vaginal fluid test to assess the risk of inflammation and / or intra-amniotic infection in women with signs and symptoms of threatened preterm labor with intact membranes.

START:2019; END:2021

“We collaborate with industry to evaluate the performance of a minimally invasive test that assesses the risk of inflammation and / or intra-amniotic infection.”

Innovation & Impact

Intra-amniotic infection is the most frequent known cause of spontaneous preterm birth, a serious public health problem owing to the high morbidity and mortality associated with premature babies, in addition to the high economic and social costs of their care. By collaborating with industry in this project, we intend to contribute to the improvement of the detection of the risk of inflammation and/or intra-amniotic infection in women with threatened preterm labor through the validation of a non-invasive test (on vaginal discharge) , motivated by the subsequent positive impact that this would bring as a non-invasive procedure.


Tere Cobo
Principal Investigator

Montse Palacio

Ana Belén Sánchez
Lab technician




    • Minimally invasive commercial kit to be implemented in the clinical setting


    San Diego, California, US

    Powered by

    With the collaboration of

    web obra social la caixa
    web cerebra
    Web proyecto cellex
    Web link ciberer
    Web link hernia diagrafmática congénita
    Ministerio de economía web link
    Red SAMID web link
    Dexeus campus link web
    fondos feder web link
    Aguaur link web